Literature DB >> 23137033

Targeting TIM-1 on CD4 T cells depresses macrophage activation and overcomes ischemia-reperfusion injury in mouse orthotopic liver transplantation.

Y Zhang1, H Ji, X Shen, J Cai, F Gao, K M Koenig, C M Batikian, R W Busuttil, J W Kupiec-Weglinski.   

Abstract

Hepatic injury due to cold storage followed by reperfusion remains a major cause of morbidity and mortality after orthotopic liver transplantation (OLT). CD4 T cell TIM-1 signaling costimulates a variety of immune responses in allograft recipients. This study analyzes mechanisms by which TIM-1 affects liver ischemia-reperfusion injury (IRI) in a murine model of prolonged cold storage followed by OLT. Livers from C57BL/6 mice, preserved at 4°C in the UW solution for 20 h, were transplanted to syngeneic recipients. There was an early (1 h) increased accumulation of TIM-1+ activated CD4 T cells in the ischemic OLTs. Disruption of TIM-1 signaling with a blocking mAb (RMT1-10) ameliorated liver damage, evidenced by reduced sALT levels and well-preserved architecture. Unlike in controls, TIM-1 blockade diminished OLT expression of Tbet/IFN-γ, but amplified IL-4/IL-10/IL-22; abolished neutrophil and macrophage infiltration/activation and inhibited NF-κB while enhancing Bcl-2/Bcl-xl. Although adoptive transfer of CD4 T cells triggered liver damage in otherwise IR-resistant RAG(-/-) mice, adjunctive TIM-1 blockade reduced Tbet transcription and abolished macrophage activation, restoring homeostasis in IR-stressed livers. Further, transfer of TIM-1(Hi) CD4+, but not TIM-1(Lo) CD4+ T cells, recreated liver IRI in RAG(-/-) mice. Thus, TIM-1 expressing CD4 T cells are required in the mechanism of innate immune-mediated hepatic IRI in OLTs. © Copyright 2012 The American Society of Transplantation and the American Society of Transplant Surgeons.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23137033      PMCID: PMC3535503          DOI: 10.1111/j.1600-6143.2012.04316.x

Source DB:  PubMed          Journal:  Am J Transplant        ISSN: 1600-6135            Impact factor:   8.086


  35 in total

1.  Immunostimulatory Tim-1-specific antibody deprograms Tregs and prevents transplant tolerance in mice.

Authors:  Nicolas Degauque; Christophe Mariat; James Kenny; Dong Zhang; Wenda Gao; Minh Diem Vu; Sophoclis Alexopoulos; Mohammed Oukka; Dale T Umetsu; Rosemarie H DeKruyff; Vijay Kuchroo; Xin Xiao Zheng; Terry B Strom
Journal:  J Clin Invest       Date:  2008-02       Impact factor: 14.808

2.  Epitope-dependent effect of anti-murine TIM-1 monoclonal antibodies on T cell activity and lung immune responses.

Authors:  Irene D Sizing; Véronique Bailly; Patricia McCoon; Wenjie Chang; Sambasiva Rao; Lourdes Pablo; Rachel Rennard; Meghan Walsh; Zhifang Li; Mohammad Zafari; Max Dobles; Leticia Tarilonte; Steven Miklasz; Gerard Majeau; Kevin Godbout; Martin L Scott; Paul D Rennert
Journal:  J Immunol       Date:  2007-02-15       Impact factor: 5.422

3.  T cell Ig domain and mucin domain 1 engagement on invariant NKT cells in the presence of TCR stimulation enhances IL-4 production but inhibits IFN-gamma production.

Authors:  Hye Sung Kim; Hyun Soo Kim; Chang Woo Lee; Doo Hyun Chung
Journal:  J Immunol       Date:  2010-03-10       Impact factor: 5.422

4.  IL-22 is required for Th17 cell-mediated pathology in a mouse model of psoriasis-like skin inflammation.

Authors:  Hak-Ling Ma; Spencer Liang; Jing Li; Lee Napierata; Tom Brown; Stephen Benoit; Mayra Senices; Davinder Gill; Kyriaki Dunussi-Joannopoulos; Mary Collins; Cheryl Nickerson-Nutter; Lynette A Fouser; Deborah A Young
Journal:  J Clin Invest       Date:  2008-02       Impact factor: 14.808

5.  The emerging role of T cell immunoglobulin mucin-1 in the mechanism of liver ischemia and reperfusion injury in the mouse.

Authors:  Yoichiro Uchida; Bibo Ke; Maria Cecilia S Freitas; Haofeng Ji; Danyun Zhao; Elizabeth R Benjamin; Nader Najafian; Hideo Yagita; Hisaya Akiba; Ronald W Busuttil; Jerzy W Kupiec-Weglinski
Journal:  Hepatology       Date:  2010-04       Impact factor: 17.425

6.  The emerging role of T cell Ig mucin 1 in alloimmune responses in an experimental mouse transplant model.

Authors:  Takuya Ueno; Antje Habicht; Michael R Clarkson; Monica J Albin; Kazuhiro Yamaura; Olaf Boenisch; Joyce Popoola; Ying Wang; Hideo Yagita; Hisaya Akiba; M Javeed Ansari; Jaeseok Yang; Laurence A Turka; David M Rothstein; Robert F Padera; Nader Najafian; Mohamed H Sayegh
Journal:  J Clin Invest       Date:  2008-02       Impact factor: 14.808

Review 7.  Toll-like receptors and adaptor molecules in liver disease: update.

Authors:  Ekihiro Seki; David A Brenner
Journal:  Hepatology       Date:  2008-07       Impact factor: 17.425

8.  CD4 T cells promote tissue inflammation via CD40 signaling without de novo activation in a murine model of liver ischemia/reperfusion injury.

Authors:  Xiuda Shen; Yue Wang; Feng Gao; Feng Ren; Ronald W Busuttil; Jerzy W Kupiec-Weglinski; Yuan Zhai
Journal:  Hepatology       Date:  2009-11       Impact factor: 17.425

9.  Type I, but not type II, interferon is critical in liver injury induced after ischemia and reperfusion.

Authors:  Yuan Zhai; Bo Qiao; Feng Gao; Xiuda Shen; Andrew Vardanian; Ronald W Busuttil; Jerzy W Kupiec-Weglinski
Journal:  Hepatology       Date:  2008-01       Impact factor: 17.425

10.  Differential engagement of Tim-1 during activation can positively or negatively costimulate T cell expansion and effector function.

Authors:  Sheng Xiao; Nader Najafian; Jay Reddy; Monica Albin; Chen Zhu; Eric Jensen; Jaime Imitola; Thomas Korn; Ana C Anderson; Zheng Zhang; Cristina Gutierrez; Thomas Moll; Raymond A Sobel; Dale T Umetsu; Hideo Yagita; Hisaya Akiba; Terry Strom; Mohamed H Sayegh; Rosemarie H DeKruyff; Samia J Khoury; Vijay K Kuchroo
Journal:  J Exp Med       Date:  2007-07-02       Impact factor: 14.307

View more
  16 in total

1.  Inhibition of Cyclin-dependent Kinase 2 Signaling Prevents Liver Ischemia and Reperfusion Injury.

Authors:  Jin Xu; Zhengze Xue; Cheng Zhang; Yuan Liu; Ronald W Busuttil; Jiamin Zhang; Jerzy W Kupiec-Weglinski; Haofeng Ji
Journal:  Transplantation       Date:  2019-04       Impact factor: 4.939

2.  T-cell immunoglobulin and mucin domain 4 (TIM-4) signaling in innate immune-mediated liver ischemia-reperfusion injury.

Authors:  Haofeng Ji; Yuanxing Liu; Yu Zhang; Xiu-da Shen; Feng Gao; Ronald W Busuttil; Vijay K Kuchroo; Jerzy W Kupiec-Weglinski
Journal:  Hepatology       Date:  2014-10-29       Impact factor: 17.425

3.  Recipient T cell TIM-3 and hepatocyte galectin-9 signalling protects mouse liver transplants against ischemia-reperfusion injury.

Authors:  Yuanxing Liu; Haofeng Ji; Yu Zhang; Xiuda Shen; Feng Gao; Xiangyi He; Gabriella A Li; Ronald W Busuttil; Vijay K Kuchroo; Jerzy W Kupiec-Weglinski
Journal:  J Hepatol       Date:  2014-10-31       Impact factor: 25.083

4.  Negative CD4 + TIM-3 signaling confers resistance against cold preservation damage in mouse liver transplantation.

Authors:  Yuanxing Liu; Haofeng Ji; Yu Zhang; Xiu-da Shen; Feng Gao; Terry T Nguyen; Xuanming Shang; Nayun Lee; Ronald W Busuttil; Jerzy W Kupiec-Weglinski
Journal:  Am J Transplant       Date:  2015-02-12       Impact factor: 8.086

5.  TIM-1 attenuates the protection of ischemic preconditioning for ischemia reperfusion injury in liver transplantation.

Authors:  Yu Zhang; Yuanxing Liu; Hui Chen; Xiaoxiao Zheng; Shangzhi Xie; Wei Chen; Haofeng Ji; Shusen Zheng
Journal:  Am J Transl Res       Date:  2017-08-15       Impact factor: 4.060

Review 6.  The divergent roles of macrophages in solid organ transplantation.

Authors:  Sahar Salehi; Elaine F Reed
Journal:  Curr Opin Organ Transplant       Date:  2015-08       Impact factor: 2.640

Review 7.  T cells in organ ischemia reperfusion injury.

Authors:  Jianhua Rao; Ling Lu; Yuan Zhai
Journal:  Curr Opin Organ Transplant       Date:  2014-04       Impact factor: 2.640

8.  Equilibrative nucleoside transporter (ENT)-1-dependent elevation of extracellular adenosine protects the liver during ischemia and reperfusion.

Authors:  Michael A Zimmerman; Eunyoung Tak; Stefan F Ehrentraut; Maria Kaplan; Antasia Giebler; Tingting Weng; Doo-Sup Choi; Michael R Blackburn; Igal Kam; Holger K Eltzschig; Almut Grenz
Journal:  Hepatology       Date:  2013-09-24       Impact factor: 17.425

Review 9.  Liver transplantation in the mouse: Insights into liver immunobiology, tissue injury, and allograft tolerance.

Authors:  Shinichiro Yokota; Osamu Yoshida; Yoshihiro Ono; David A Geller; Angus W Thomson
Journal:  Liver Transpl       Date:  2016-04       Impact factor: 5.799

10.  Protocol TOP-Study (tacrolimus organ perfusion): a prospective randomized multicenter trial to reduce ischemia reperfusion injury in transplantation of marginal liver grafts with an ex vivo tacrolimus perfusion.

Authors:  Sebastian Pratschke; Michael Eder; Michael Heise; Silvio Nadalin; Andreas Pascher; Peter Schemmer; Marcus N Scherer; Frank Ulrich; Heiner Wolters; Karl-Walter Jauch; Dirk Wöhling; Martin K Angele
Journal:  Transplant Res       Date:  2013-03-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.